Cm Management, LLC Durect Corp Transaction History

Cm Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	BUY	$0.38 - $0.64 $81,421 - $137,131	214,268 Added 6.06%	3,750,000 $1.79 Million
Q1 2022 May 09, 2022	BUY	$0.55 - $0.98 $335,795 - $598,326	610,537 Added 20.87%	3,535,732 $2.37 Million
Q4 2021 Feb 02, 2022	BUY	$0.9 - $1.31 $247,675 - $360,505	275,195 Added 10.38%	2,925,195 $2.88 Million
Q4 2020 Feb 04, 2021	BUY	$1.65 - $2.43 $4.37 Million - $6.44 Million	2,650,000 New	2,650,000 $5.49 Million

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $171M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Cm Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cm Management, LLC with notifications on news.